Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease

Elevated low-density lipoprotein cholesterol (LDL-C) level is associated with an increased risk of atherosclerotic cardiovascular disease. Although high-intensity lipid-lowering therapies with statins and ezet...

Source: Cardiovascular Diabetology - January 30, 2023 Category: Cardiology Authors: Toshiyuki Nishikido Tags: Review Source Type: research